Finding possible pharmacological effects of identified organic compounds in medicinal waters (BTEX and phenolic compounds)

  • István SzabóEmail author
  • Csaba Varga
Open Access
Special Issue: Balneology


Medicinal thermal waters consist of a mixture of different organic and inorganic compounds. Traditionally, these waters are only characterized and classified by their inorganic composition; however, the bioavailability of the majority of these inorganic compounds is limited. Many authors investigate the organic fractions of thermal waters. These authors propose that these compounds have a potential effect on health. To elucidate the underlying mechanisms, it is crucial to know the composition of the organic fractions. The absorption of these compounds on intact skin or mucosa is notable. Some of them have local anaesthetic effect or affect receptors in the central nervous system. In the knowledge of the chemical composition, we are able to estimate the possible pharmacological effect or might be able to assess possible toxicity risks. In the present article, we aim to review possible health effects of two of the identified organic fractions: benzene and alkylbenzenes and phenolic compounds that might correlate with the therapeutic effect on rheumatological or other diseases.


Thermal water Organic compounds Medicinal water Therapeutic effect Organic theory BTEX Phenolic compounds 


The medical treatment of pain in musculoskeletal or rheumatic disorders mostly involves analgesic drugs. Despite their potency, other additional methods are often needed. Balneotherapy is a well-known and effective auxiliary treatment without severe side effects (Bender et al. 2005). Many of these well-known waters are proven to have a positive effect on certain diseases, such as rheumatological disorders like fibromyalgia or dermatological problems; thus, they are referred to as medicinal waters (Fioravanti et al. 2018; Péter et al. 2017; Varga 2012a). Many of these thermal waters have been used for centuries. Oral traditions and observations attest their effect. Organizing and controlling a balneotherapy study is problematic. Furthermore, research funding is insufficient. A traditional knowledge of healing effect is rarely supported by randomised controlled trials (Bender et al. 2005). Following the concept of evidence-based medicine, Bender et al. (2014) proposed evidence-based balneotherapy. From the pharmacological point of view, high-quality human evidence is needed to prove the effectiveness of medicinal therapies. This evidence relates to the exact formulation, exposure and pharmacokinetics that were investigated in the precise clinical trial. In classical pharmacology, the precise pharmacodynamic mechanisms of some of the most prevalent medicine have not been elucidated yet (for example lithium) (Malhi et al. 2013). In clinical trials, only the efficiency needs to be proved. Furthermore, some compounds have been used for centuries and marketed as medicine for more than a century. As the evidence-based medicine concept and rigorous efficiency and toxicological trials appeared in the middle of the twentieth century, these medicines are without these evidences (Sur and Dahm 2011). As balneotherapy has been used for millennia, the therapeutic use of medicinal waters belongs to the same category (Gutenbrunner et al. 2010; Bender et al. 2005, 2014). The last two decades abound in evidence from randomized controlled trials and their meta-analyses. In these studies, usually a selected method of balneology was investigated mainly in rheumatic diseases. These pieces of evidence confirm the experience-based use of balneotherapy (Bender et al. 2014; Fioravanti et al. 2017). Medical significance of the organic fractions of natural waters is still poorly understood. The classical hypothesis of the categorisation of spa waters is based on analysing the inorganic contents and marks only the total organic matter content (Varga 2010). The reason for this type of classification is that inorganic quantitative and qualitative analyses are easy to conduct. From the medical point of view, the utilization of these classifications is faulty. Firstly, the dermal bioavailability of most of these salts is poor considering that most of the balneotherapy involves immersion in medicinal water or peloid packs (Shani et al. 1985; Gröber et al. 2017). Secondly, the organic matter content is outstanding concerning the quantity and the diversity of the compounds too (Kárpáti et al. 1999; Fekete et al. 2009). Furthermore, the dermal intake of many of these compounds (phenolics, BTEX compounds) is remarkable (Lim et al. 2014; Monteiro-Riviere et al. 2001).

In the recent past, several authors proposed that medicinal waters, especially thermal spa and hot spring waters, contain a high variability of organic components with possible biological effects that might contribute to the healing mechanisms (Fekete et al. 2012; González-Barreiro et al. 2009; Varga 2012b). Varga and his coworkers have been investigating both benign (curative) and disadvantageous (toxic) effects of the organics in thermal waters. They claim that many of these organic compounds are highly bioactive in the scope of other scientific fields. Therefore, these fractions cannot be neglected when discussing balneology (Varga et al. 1992; summarized in Varga 2012a). González-Barreiro et al. also identified organic compounds in several Spanish traditional medicinal waters that “are responsible for the biological activity of thermal waters” (González-Barreiro et al. 2009). Fekete et al. found great importance of analysing the organic content of thermal waters, because “thermal waters are used for balneologic purposes and organic compounds may contribute to the curative power” (Fekete et al. 2012). Hanzel et al. conducted the first clinical trial that investigates organic content separately. Organic fraction of Szigetvár medicinal water was separated and later diluted by heated tap water. As a result of this process, an artificial medicinal water was created without the original inorganic content. The investigated parameters for osteoarthritis were significantly better compared with that of tap water control, which proves the beneficial effect of the organic matter (Hanzel et al. 2019). Analytical researches provide us with the actual organic matter composition. However, selecting a single compound or groups of chemicals from this entity and assign pharmacological mechanisms based on available evidences is only of theoretical interest. In the absence of proper pharmacokinetic data and models from balneotherapy, this is impossible. In most cases, the applied concentrations do not match the concentration found in thermal waters. When searching for evidence in balneotherapy, the best strategy is to conduct human clinical trials testing the whole thermal water or selected fractions of the thermal water.

This review aims to gather evidence where the effect of the organic compounds matches the effect of balneotherapy. In the present article, we select two groups of organic matter, benzene/alkylbenzenes and phenolic compounds, to review possible pharmacological effect or mechanisms of action that might correlate to the pharmacological effect of medicinal waters. These pharmacological effects or mechanisms of action might be in the focus of future balneopharmacological studies.

Organic chemical analysis of thermal waters

The first organic analytical investigations in Hungary were carried out by Agyagási. He identified open-chain olefins in thermal waters (Agyagási 1983). Since the 1990s, several researchers have investigated the organic content of thermal waters of the Carpathian Basin (Vető and Bertalanné Balogi 1994; Kárpáti et al. 1999; Fekete et al. 2009; Fekete 2013). The balance of organic and inorganic components was studied in thermal waters. The decomposition of organic matter produces small molecular-sized aromatic compounds and also influences the amounts of inorganic components (Fekete et al. 2009). The decomposition of organic matter is strongly linked to a temperature threshold. As the temperature of the water increases, organic matter decomposes and the concentration of dissolved aromatics (benzene homologues, phenols) increases. Depending on the temperature, different homologue series appear, aromatic hydrocarbons dominate at a threshold of 80 °C, phenols at 90 °C and in those hotter than 90  C fatty acids can be identified (Fekete et al. 2012).

Thermal waters were classified to phenol free and phenolic waters. Phenols are the predominant aromatic compounds of hotter waters, while benzene and alkylbenzenes dominate in lower concentrations (Kárpáti et al. 1999; Fekete 2013). The identified organic matter (especially BTEX (benzene, toluene, ethylbenzene, xylenes) compounds) can originate from environmental pollution caused by petrol consumption or the co-existence of underground oil reservoirs. In the reviewed articles, the investigated thermal waters did not have any connection with oil pollutants or natural oil sources (Kárpáti et al. 1999; Fekete et al. 2009; Fekete 2013).

In several thermal waters, phenol and simple phenol derivatives with ethyl and methyl substituents were identified. The concentrations of these compounds range from 1 μg/L up to 1–2 mg/L. Among many other aromatic compounds, these phenolic compounds originate from humic substances or lignite, which decompose to carbon dioxide, hydrocarbon gases and water soluble aromatic compounds (alkylbenzenes, polycyclic aromatic hydrocarbons (PAH), heteroaromatic compounds). The main groups of organic matter were humic substances, benzene and alkylbenzenes, PAH and phenolic compounds (Fekete 2013). Kompanichenko et al. analysed the thermal waters of the Uzon caldera and the Mutnovskii geothermal area. The researchers identified the following organic chemical groups: alkanes, aromatic hydrocarbons, ketones, alcohols (Kompanichenko et al. 2016). Szabó et al. reviewed the possible pharmacological effect of the organic matters identified in Kakasszék medicinal water. Kakasszék is a phenolic type of water. The main compounds were simple phenol derivatives (Szabó et al. 2013).

González-Barreiro analysed water samples from four open water springs of Galicia thermal spa region. They identified several chemical families including N-compounds, heterocyclics, amines, aromatic hydrocarbons, esthers, ketones and phenols. Volatile aromatic hydrocarbons benzene, ethylbenzene and xylenes were detected in all of the samples; however, the concentrations were relatively low. Such compounds are the product of thermal degradation of essential organic chemicals such as carotenoids or amino acids. Several alkylphenols were also identified in all samples. The concentrations ranged from 9 to 15%. These compounds originate from lignin-rich aquifers or maturation of thermal waters (González-Barreiro et al. 2009).

Benzene and alkylbenzenes

Precise kinetic data from inhalation and dermal absorption of alkylbenzenes are not available from the field of balneology. BTEX compounds as toxic exposure are prevalent in petrol industry. Exposure to BTEX compounds in petrol industry workers was measured along with the concentration of chemicals in ambient air. Mean urinary volatile organic compound (VOC) concentrations ranged up to 11.83 μg/L for highly exposed loading workers and 2.58 μg/L for office workers (Heibati et al. 2018). Biomonitoring after inhalation exposure of mixed BTEX compounds is modelled and is available (Marchand et al. 2015). Urinary VOC concentration biomonitoring could be a possible measure to BTEX exposure during balneotherapy. As benzene and alkylbenzenes are prevalent (eco)toxic compounds, many authors reviewed the toxicology of them (IARC Monograph vol. 120 (2017); Bolden et al. 2015; Heibati et al. 2018). Many drug users (even heavy drug users—poly drug use) chose solvents or glues to inhale their volatile compounds for the dazzling sensation and euphoric properties. These are mainly caused by benzene derivatives, so toluene is also extensively reviewed (Cruz et al. 2014). Studies have shown that neurotransmitter systems (glutamatergic, opioidergic, GABAergic (gamma-aminobutyric acid)) are affected by benzene derivatives (Páez-Martinez et al. 2008). VOCs and toluene have nonselective actions on several voltage-gated ion channels and neurotransmitters in the central nervous system (CNS). They disturb the native balance of ligand-gated ionic channels found in the CNS. Toluene inhibits some excitatory ion channels such as the nicotinic acetylcholine receptors (nAChRs) and N-methyl-d-aspartate (NMDA) glutamate receptors. Toluene potentiates the inhibitory channels, such as serotonin, glycine and GABAA receptors (Bale et al. 2007; Woodward and Beckley 2014). According to the ion channel hypothesis, the acute effect of toluene and VOCs is due to affecting specific ion channels of targets in the CNS. Despite the knowledge of these mechanisms, their overall effect and relative importance is still under investigation (Bale et al. 2007; Evans and Balster 1991; Woodward and Beckley 2014). It is not just a coincidence that in mood disorders, the disturbance of norepinephrine, dopamine, acetylcholine, glutamate and GABA receptors were reported as biological abnormalities, thus basing the neurotransmitter theories (Hassler 2010). Positive modulation of the GABAA receptor is the common mechanism of certain CNS depressants. Solvents like benzene and toluene showed anxiolytic-like effect when tested in animal experiments. This effect is based on the positive modulation of GABAA receptors, which is a common mechanism of action with other CNS depressants as well (Bowen et al. 2006). Certain antidepressant drugs increase noradrenaline and serotonin levels in corresponding brain areas. Many solvents, like toluene, have the same effect. The antidepressant effect of toluene was tested on two animal models capable of screening possible antidepressants. Toluene exerted concentration-dependent antidepressant effect (Cruz et al. 2009). Páez-Martinez et al. investigated a single toluene exposure in connection with morphine administration. When given simultaneously, toluene counteracted the effect of morphine, thus exerting a nociceptive effect. Mu-opioid receptor binding levels were also investigated in different parts of the brain of mice exposed to a single dose of toluene (4000 ppm). The binding levels significantly decreased. Based on these results, toluene exposure might have an effect on analgesic effect of opioids (Páez-Martinez et al. 2008).

Phenolic compounds

Aromatic compounds have been used in medical sciences for centuries. Phenol was introduced by Lister for disinfectant or antiseptic purposes in medicine. The tissue necrotic effect of phenol is well known (Wood 1978). Since the discovery of Lister, the antiseptic use of phenol faded. It has been replaced with safer and more potent substances concerning antimicrobial activity (Davidson and Branden 1981). The domestic use of concentrated phenol solutions for disinfection is obsolete in the scope of chemical safety rules of today. However, some countries are still manufacturing such products. These products are used for veterinarian, household cleaning and human delousing purposes. Even in the near past chemical burns caused by such products were reported (Vearrier et al. 2015). Cosmetic surgeons use a type of deep chemical peel called phenol face peeling. They apply phenol solution on the face to remove imperfections such as acne scars, wrinkles and blotchiness (Park et al. 2007). Botta et al. reviewed several case reports from cosmetic surgeons and the incidence of arrhythmias in some cases was as high as 23%. Even that time this was considered unacceptable. Therefore, they proposed a new protocol involving cardiac monitoring, fluid loading and the use of prophylactic antiarrhythmic agent lidocaine (Botta et al. 1988). The local anaesthetic effect of phenol is used in peeling creams too (Ruiz-Maldonado 1997). Although acute phenol exposure can lead to severe symptoms, once recovered, long-term effects are not expected to appear (Vearrier et al. 2015). Phenol peel is used today, but the protocols are strict and the applied products have lower side effect profile (Park et al. 2007). In modern medicine, phenolics are also present as technological materials or standalone active substances. The latest implemented Pharmacopoea Hungarica VIII contains monographs on phenol, cresol and resorcinol used for medicinal purposes (Pharmacopoea Hungarica VIII 2003). The Formulae Normales VII (official magistral recipe collection of Hungary) contains three types of antiseptic and antifungal topical solutions, called Solutio Castellani (boric acid, phenol, resorcinol in ethanol solution) (Formulae Normales VII 2003). The other well-known property of phenol is the local anaesthetic effect. In otolaryngology, phenol has been used to anaesthetize the tympanic membrane since 1907. This method is questionable because of possible damage to the tympanic membrane and the cochlea, as phenol exerts neurotoxic effect and a potential hazard for sensorineural hearing loss (Robertson et al. 2006). Medicine also uses phenol to treat haemorrhoids. Liquefied phenol content of ointments absorbs well and rapidly from the skin. Acting on the sensory nerves, it causes numbness and decreases itching sensation. Injection sclerotherapy for haemorrhoids involves 5% phenol dissolved in almond oil (PAO). Potassium aluminium sulphate and tannic acid (ALTA) are used as additives (Yano and Yano 2015; Acheson and Scholefield 2008). A classical usage of phenolics is to treat warts and verrucas (Dalimunthe et al. 2018). Several traditional non-official magistral medicine contained phenol, cresol, resorcine and salycilic acid, mainly dissolved in aether or collodion (aetheric solution of cellulose nitrate). In today’s medicine, these medicines are sporadic. Salicylic acid replaced phenolics. Despite the traditional usage of phenolics to treat warts, Kwok et al. excluded 80% phenol from reviewing, because according to the collected trials, the treatment showed no advantage over placebo (Kwok et al. 2012). Percutaneous neurolysis is a way to manage pain especially among cancer patients. A chemical agent (usually 3–20% phenol or absolute ethanol) is injected in the corresponding area of the sympathetic plexus or peripheral nerves. During chemical neurolysis, the chemicals cause sensory nerve damage, thus blocking the nociceptive signals (Filippiadis et al. 2009). The chemicals cause Wallerian degeneration, which is a controlled self-destruction of the axons; the axon is dying back (Coleman and Freeman 2010). Another possible mechanism of action might be the ryanodine receptor (RyR) modulation of phenolics. Ryanodine receptors have an important role in the regulation of intracellular calcium levels in the nervous system and muscle. RyR has several well-known chemical modulators. Some pharmacons act as activators (caffeine, halothane), while others exert inhibitory effect (neomycin). A well-known activator of RyR is 4-chloro-m-cresol (4-CmC) (Van Petegem 2012). Not only does this halogenated phenolic compound activates RyR but also other phenolics are able to exert partial or full activation as well. Jacobson et al. studied several structural analogues of 4-CmC concerning their ability to activate RyR1. In vitro binding and in vivo cell line analyses were used to test the analogues. They concluded that the hydroxyl group at position 1 is essential. Several other substituents were also tested. Among these substituents 3,4-dimethilphenol (3,4-xylenol) was an agonist with smaller activation potential than 4-CMC (Jacobson et al. 2006). In the aforementioned analytical studies of thermal waters, 3,4-dimethilphenol was present. There are several other types of phenolic compounds reported as phenol derivatives too (Fekete 2013; Kompanichenko et al. 2016). These compounds might have the same effect on RyR1.


As BTEX compounds and other alkyl benzenes are considered toxic and environmental pollutants, it should be mentioned that they are hazardous chemicals that might have a toxicological effect during balneotherapy. For this reason, several balneotoxicological studies were conducted (Gerencsér et al. 2010; Szendi et al. 2012). Medicinal waters contain these chemicals. During balneotherapy, people are exposed to them by dermal absorption and inhalation or oral exposure. As many inhalant abusers consume the same chemicals, we can hypothesise that people who underwent balneotherapy with waters containing high BTEX and alkylbenzene suffer a low-dose abuse of these chemicals. The dose is lower than in the case of solvent abuse. However, in the case of a full-day exposure, where most of the time the person submerges in medicinal water and inhales the vapours all day, these exposures are cumulating. Glutaminerg NMDA receptors can be found in the spinal cord. They are in connection with nociceptive neurotransmission. In persistent pain states, central sensitisation is important. Glutaminerg NMDA receptors are involved in this process (Das 2015). Taking into account that benzene acts on these receptors, it might be involved in chronic pain as well. Simple phenolics in medicine are used in higher concentration than that of medicinal waters. We do not know the proper pharmacokinetics. We can suppose that the absorbed simple phenolics act as local anaesthetics and thus contribute to the effect of medicinal waters in painful musculoskeletal disorders. At least one compound is present in phenolic medicinal waters that have an agonist effect on RyR1 (3,4-dimethylphenol). The ryanodine receptor calcium release channel that can be found in several organs including skeletal muscles, CNS and the heart. It is responsible for many different functions (Dulhunty et al. 2018). Excess Ca2+ release from RyR is in connection with muscle weakness in rheumatoid arthritis (Yamada et al. 2017). RyR is in connection with wound healing. RyR antagonist dantrolene positively affected wound healing in mouse wound healing models (Degovics et al. 2019). RyR modulates several biochemical pathways and is able to react to chemicals from the inflammation cascade. The precise role of RyR in inflammatory response has not been elucidated yet (Buck and Ehrlich 2005). It is notable that antagonists of the RyR are able to exert positive health effects (Hopp et al. 2015). 3,4-Dimethilphenol is an agonist of the receptor. The possible treatment of cutaneous warts by medicinal water is rooted from case reports and long-time experience. Gülec et al. investigated a small number of organ transplant patients with thermal water and heated tap water. They achieved negative results, but concluded that different types of thermal water should be tested for the same purpose (Güleç 2018).



Open access funding provided by University of Pécs (PTE).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Acheson AG, Scholefield JH (2008) Management of haemorrhoids. BMJ 336(7640):380–383. CrossRefGoogle Scholar
  2. Agyagási D (1983) (Investigation of organic components of different types of waters.) article in Hungarian. Balneológia Gyógyfürdőügy Gyógyidegenforgalom 4:261–268Google Scholar
  3. Bale AS, Jackson MD, Krantz QT, Benignus VA, Bushnell PJ, Shafer TJ, Boyes WK (2007) Evaluating the NMDA-glutamate receptor as a site of action for toluene, in vivo. Toxicol Sci 98(1):159–166. CrossRefGoogle Scholar
  4. Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25(3):220–224. CrossRefGoogle Scholar
  5. Bender T, Bálint G, Prohászka Z, Géher P, Tefner IK (2014) Evidence-based hydro- and balneotherapy in Hungary—a systematic review and meta-analysis. Int J Biometeorol 58:311–323. CrossRefGoogle Scholar
  6. Bolden AL, Kwiatkowski CF, Colborn T (2015) New look at BTEX: are ambient levels a problem? Environ Sci Technol 49(9):5261–5276. CrossRefGoogle Scholar
  7. Botta SA, Straith RE, Goodwin HH (1988) Cardiac arrhythmias in phenol face peeling: a suggested protocol for prevention. Aesthet Plast Surg 12(2):115–117. CrossRefGoogle Scholar
  8. Bowen SE, Batis JC, Paez-Martinez N, Cruz SL (2006) The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28:636–647. CrossRefGoogle Scholar
  9. Buck ED, Ehrlich BE (2005) Ryanodine receptor function in inflammation in: ryanodine receptors - structure, function and dysfunction in clinical disease. In: Wehrens XHT, Marks AR (eds) . Springer Science + Business Media, Inc., pp 169–178.
  10. Coleman MP, Freeman MR (2010) Wallerian degeneration, WldS, and Nmnat. Annu Rev Neurosci 33:245–267. CrossRefGoogle Scholar
  11. Cruz SL, Soberanes-Chávez P, Páez-Martinez N, López-Rubalcava C (2009) Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs. Psychopharmacology 204:279–286. CrossRefGoogle Scholar
  12. Cruz SL, Rivera-García MT, Woodward JJ (2014) Review of toluene action: clinical evidence, animal studies and molecular targets. J Drug Alcohol Res 3:235840. CrossRefGoogle Scholar
  13. Dalimunthe DA, Siregar R, Tanjung C (2018) Comparative clinical efficacy between electrodesiccation with curettage and application of 80% phenol solution in treatment of common warts. Open Access Maced J Med Sci 6(2):326–329. CrossRefGoogle Scholar
  14. Das V (2015) An introduction to pain pathways and pain “targets” In: Price TJ, Dussor G (eds) Molecular and cell biology of pain. Prog Mol Biol Transl Sci 131:1–30. Google Scholar
  15. Davidson PM, Branden AL (1981) Antimicrobial activity of non-halogenated phenolic compounds. J Food Prot 44(8):623–632. CrossRefGoogle Scholar
  16. Degovics D, Hartmann P, Németh IB, Árva-Nagy N, Kaszonyi E, Szél E, Strifler G, Bende B, Krenács L, Kemény L, Erős G (2019) A novel target for the promotion of dermal wound healing: ryanodine receptors. Toxicol Appl Pharmacol 1(366):17–24. CrossRefGoogle Scholar
  17. Dulhunty AF, Beard NA, Casarotto MG (2018) Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling. F1000Res 7(F1000 Faculty Rev):1851. CrossRefGoogle Scholar
  18. Evans EB, Balster RL (1991) CNS depressant effects of volatile organic solvents. Neurosci Biobehav R 15:233–241. CrossRefGoogle Scholar
  19. Fekete J (2013) Investigation of aromatic compounds in thermal water and the modelling of their formation. In: Hungarian. PhD dissertation, University of Szeged, Hungary. Accessed 15 Aug 2019
  20. Fekete J, Sajgó CS, Horváth I, Kárpáti Z, Vető I, Hetényi M (2009) Interaction and variation of isotopic age, temperature, organic and inorganic solutes in Hungarian thermal waters. Cent Eur Geol 52(3–4):269–285. CrossRefGoogle Scholar
  21. Fekete J, Sajgó CS, Kramarics Á, Eke ZS, Kovács K, Kárpáti Z (2012) Aquathermolysis of humic and fulvic acids: simulation of organic matter maturation in hot thermal waters. Org Geochem 53:109–118. CrossRefGoogle Scholar
  22. Filippiadis DK, Tselikas L, Tsitskari M, Kelekis A, Thierry de Baere T, Ryan AG (2009) Percutaneous neurolysis for pain management in oncological patients. Cardiovasc Intervent Radiol. CrossRefGoogle Scholar
  23. Fioravanti A, Karagülle M, Bender T, Karagülle MZ (2017) Balneotherapy in osteoarthritis: facts, fiction and gaps in knowledge. Eur J Integr Med 9:148–150. CrossRefGoogle Scholar
  24. Fioravanti A, Manica P, Bortolotti R, Cevenini G, Tenti S, Paolazzi G (2018) Is balneotherapy effective for fibromyalgia? Results from a 6-month double-blind randomized clinical trial. Clin Rheumatol 37(8):2203–2212. CrossRefGoogle Scholar
  25. Formulae Normales Editio VII (2003) Ed Paál T. Országos Gyógyszerészeti Intézet, Hungary. Accessed 15 Aug 2019
  26. Gerencsér G, Murányi E, Szendi K, Varga Cs (2010) Ecotoxicological studies on Hungarian peloids (medicinal muds). Appl Clay Sci 50:47–50. CrossRefGoogle Scholar
  27. González-Barreiro C, Cancho-Grande B, Araujo-Nespereira P, Cid-Fernández JA, Simal-Gándara J (2009) Occurrence of soluble organic compounds in thermal waters by ion trap mass detection. Chemosphere 75:34–47. CrossRefGoogle Scholar
  28. Gröber U, Werner T, Vormann J, Kisters K (2017) Myth or reality—transdermal magnesium? Nutrients 9(8):813. CrossRefGoogle Scholar
  29. Güleç AT (2018) Natural thermal spa water versus hyperthermic tap water for treatment of recalcitrant hand warts in organ transplant recipients: a patient-blinded, comparative preliminary study. Exp Clin Transplant 16(Suppl 1):189–193. CrossRefGoogle Scholar
  30. Gutenbrunner C, Bender T, Cantista P, Karagülle Z (2010) A proposal for a worldwide definition of health resort medicine, balneology, medical hydrology and climatology. Int J Biometeorol 54(5):495–507. CrossRefGoogle Scholar
  31. Hanzel A, Berényi K, Horváth K, Szendi K, Németh B, Varga Cs (2019) Int. J Biometeorol 63(4):449–458. CrossRefGoogle Scholar
  32. Hassler G (2010) Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9(3):155–161. CrossRefGoogle Scholar
  33. Heibati B, Godri Pollitt KJ, Charati JY, Ducatman A, Shokrzadeh M, Karimi A, Mohammadyan M (2018) Biomonitoring-based exposure assessment of benzene, toluene, ethylbenzene and xylene among workers at petroleum distribution facilities. Ecotoxicol Environ Saf 149:19–25. CrossRefGoogle Scholar
  34. Hopp SC, Royer SE, D’Angelo HM, Kaercher RM, Fisher DA, Wenk GL (2015) Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus. J NeuroImmune Pharmacol 10(1):35–44. CrossRefGoogle Scholar
  35. IARC (2017) Monographs on The Evaluation of Carcinogenic Risk to Humans, volume 120 Benzene (Lyon, France) Accessed 15 Aug 2019Google Scholar
  36. Jacobson AR, Moe ST, Allen PD, Fessenden JD (2006) Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1. Mol Pharmacol 70(1):259–266. CrossRefGoogle Scholar
  37. Kárpáti Z, Sajgó CS, Vető I, Klopp G, Horváth I (1999) Organic matter in thermal waters of the Pannonian Basin - a preliminary report on aromatic compounds. Org Geochem 30:701–712. CrossRefGoogle Scholar
  38. Kompanichenko VN, Poturaya VA, Karpovb GA (2016) Organic compounds in thermal water: the Mutnovskii area and the Uzon caldera. J Volcanol Seismol 10(5):305–319. CrossRefGoogle Scholar
  39. Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R (2012) Topical treatments for cutaneous warts (review). Cochrane Database Syst Rev 9:CD001781. CrossRefGoogle Scholar
  40. Lim SK, Shin HS, Yoon KS, Kwack SJ, Um YM, Hyeon JH, Kwak HM, Kim JY, Kim TH, Kim YJ, Roh TH, Lim DS, Shin MK, Choi SM, Kim HS, Lee BM (2014) Risk asssessment of volatile organic compounds benzene, toluene, ethylbenzene, and xylene (BTEX) in consumer products. J Toxicol Environ Health A 77(22–24):1502–1521. CrossRefGoogle Scholar
  41. Malhi GS, Tanious M, Das P, Coulston CM, Berk M (2013) Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs 27(2):135–153. CrossRefGoogle Scholar
  42. Marchand A, Aranda-Rodriguez R, Tardif R, Nong A, Haddad S (2015) Human inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine. Toxicol Sci 144(2):414–424. CrossRefGoogle Scholar
  43. Monteiro-Riviere NA, Inman AO, Jackson H, Dunn B, Dimond S (2001) Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin. Toxicol Ind Health 17(4):95–104. CrossRefGoogle Scholar
  44. Páez-Martinez N, Ambrosio E, Garcia-Lecumberri C, Rocha L, Montoya GL, Cruz SL (2008) Toluene and TCE decrease binding to mu-opioid receptors, but not to benzodiazepine and NMDA receptors in mouse brain. Ann N Y Acad Sci 1139:390–401. CrossRefGoogle Scholar
  45. Park JH, Choi YD, Kim SW, Kim YC, Park SW (2007) Effectiveness of modified phenol peel (Exoderm) on facial wrinkles, acne scars and other skin problems of Asian patients. J Dermatol 34(1):17–24. CrossRefGoogle Scholar
  46. Péter I, Jagicza A, Ajtay Z, Boncz I, Kiss I, Szendi K, Kustán P, Németh B (2017) Balneotherapy in psoriasis rehabilitation. In Vivo 31(6):1163–1168. CrossRefGoogle Scholar
  47. Pharmacopoea Hungarica VIII (2003) edition. Medicina, BudapestGoogle Scholar
  48. Robertson A, Whitwell R, Osborne J (2006) Is phenol a safe local anaesthetic for grommet insertion? J Laryngol Otol 120:20–23. CrossRefGoogle Scholar
  49. Ruiz-Maldonado R (1997) Saturated phenol as a local anesthetic for manual dermabrasion. Dermatol Surg 23:187–190. CrossRefGoogle Scholar
  50. Shani J, Barak S, Levi D, Ram M, Schachner ER, Schlesinger T, Robberecht H, Van Grieken R, Avrach WW (1985) Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solutions. Pharmacol Res Commun 17(6):501–512. CrossRefGoogle Scholar
  51. Sur RL, Dahm P (2011) History of evidence-based medicine. Indian J Urol 27(4):487–489. CrossRefGoogle Scholar
  52. Szabó I, Gerencsér G, Varga Cs (2013) [Selected effects of organic materials of Hungarian spa waters, a mass spectrometric analysis] Hungarian, Annual Congress of Hungarian Balneological Society Mezőkövesd, Hungary, November 15th–17th, 2013Google Scholar
  53. Szendi K, Gerencsér G, Murányi R, Varga Cs (2012) Mutagenic activity of peloids in the Salmonella Ames test. Appl Clay Sci 55:70–74. CrossRefGoogle Scholar
  54. Van Petegem F (2012) Ryanodine receptors: structure and function. J Biol Chem 287(38):31624–31632. CrossRefGoogle Scholar
  55. Varga Cs (2010) Problems with classification of spa waters used in balneology. Health 2(11):1260–1263. CrossRefGoogle Scholar
  56. Varga Cs (2012a) Balneoprevention: new approaches. Int J Biometeorol 56:195–197. CrossRefGoogle Scholar
  57. Varga Cs (2012b) Volatile organics in thermal spa waters: active ingredients or environmental toxicants? Therm and Spa Med 1:1Google Scholar
  58. Varga Cs, Groska L, Kocsár B, Major Z, Vinczi F (1992) Extract comprising organic components of natural water, process for producing them and cosmetics comprising this extract. Hungarian patent No 215130Google Scholar
  59. Vearrier D, Jacobs D, Greenberg MI (2015) Phenol toxicity following cutaneous exposure to Creolin®: a case report. J Med Toxicol 11(2):227–231. CrossRefGoogle Scholar
  60. Vető I, Bertalanné Balogi M (1994) A hazai hévizes zóna kőzeteinek szerves anyaga (mennyiség, típus, érettség). Kárpát-medence vízkészlete és vízi környezetvédelme kongresszus I-II, Magyar Hidrológiai Társaság, Eger, 1994. október 17–21, I. kötet, 249–257. Conference abstract in HungarianGoogle Scholar
  61. Wood KM (1978) The use of phenol as a neurolytic agent: a review. Pain 5:205–229. CrossRefGoogle Scholar
  62. Woodward JJ, Beckley J (2014) Effects of the abused inhalant toluene on the mesolimbic dopamine system. J Drug Alcohol Res 3:235–238. CrossRefGoogle Scholar
  63. Yamada T, Steinz MM, Kenne E, Lanner JT (2017) Muscle weakness in rheumatoid arthritis: the role of Ca2+ and free radical signaling. EBioMedicine 23:12–19. CrossRefGoogle Scholar
  64. Yano T, Yano K (2015) Comparison of injection sclerotherapy between 5% phenol in almond oil and aluminum potassium sulfate and tannic acid for grade 3 hemorrhoids. Ann Coloproctol 31(3):103–105. CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Department of Environmental Health, Institute of Public Health Medicie, Medical SchoolUniversity of PécsPécsHungary

Personalised recommendations